Hospitals should act now to notify patients about research use of their data and biospecimens
- 11 March 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (3), 306-308
- https://doi.org/10.1038/s41591-020-0795-6
Abstract
Private industry is increasingly soliciting hospitals to sell or share health data and biospecimens, but current laws offer more disclosure and consent protections for research participants than for patients receiving clinical care. Hospitals can offer more protections than required by law, however, and should move toward greater transparency with their patients about the research use of clinical health data and biospecimens to respect patients and avoid distrust.This publication has 11 references indexed in Scilit:
- 3313 “My research is their business, but I’m not their business”: Patient and Oncologist Perspectives on the Commercialization of Research DataJournal of Clinical and Translational Science, 2019
- Shadow health records meet new data privacy lawsScience, 2019
- Privacy in the age of medical big dataNature Medicine, 2019
- The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its MatchThe Oncologist, 2018
- Encouraging Participation And Transparency In Biobank ResearchHealth Affairs, 2018
- Perspectives of Patients With Cancer on the Ethics of Rapid-Learning Health SystemsJournal of Clinical Oncology, 2017
- Immortal Life of the Common Rule: Ethics, Consent, and the Future of Cancer ResearchJournal of Clinical Oncology, 2017
- Informed ConsentThe New England Journal of Medicine, 2017
- Muscle-type Identity of Proprioceptors Specified by Spatially Restricted Signals from Limb MesenchymeCell, 2016
- An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical EthicsHastings Center Report, 2013